Uncertainty and erratic moves will be the norm rather than the exception reports Saxo Bank, the online trading and investment specialist, in its economic outlook for the third quarter of 2011. The second half of 2011 will be volatile and the uncertainty almost as great as during the financial crisis.
The most probable outlook for Q3 is that the world extends monetary stimulus across the global economies. This will bring marginal higher growth but also increase the burden on fiscal payments and a need for structural changes. Any long-term solution needs to be forward looking and involve an agenda for dragging Europe out of the low growth stalemate. A solution based on buying more time will only take us closer to the feared full blown Crisis 2.0.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/saxobank/50522/
The second annual “SEND ME 2 VEGAS” sweepstakes begins today, giving one fan a chance to win a 2012 Ford Explorer XLT SUV valued at up to $33,000, two VIP tickets to NASCAR After The Lap™, the opportunity to be featured in an on-air promotional spot on GSN (Game Show Network), a two-night stay at Hard Rock Hotel and Casino Las Vegas and more.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52092-send-me-2-vegas-sweepstakes-2012-ford-explorer-vip-trip-nascar
After an unexpected diagnosis of atrial fibrillation (AFib), a type of irregular heart beat they had never heard of before, daytime TV star Susan Lucci and her husband Helmut Huber learned he is one of the estimated 2.3 million Americans living with the condition, which can increase the risk of stroke nearly five-fold. The couple, who have spent more than a decade working with their doctor to help minimize Helmut’s stroke risk, today announced they have partnered with Boehringer Ingelheim Pharmaceuticals, Inc., National Stroke Association and StopAfib.org to launch a new national education program to improve awareness of AFib and its increased risk of stroke.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/boehringer-ingelheim/46196/
Visit http://www.tablesawpushstick.com
Learning to rip wood on the tablesaw in a safe and anxiety free manner has to be taught. This video teaches the best techniques, then go to video Part 2.
Shortcuts.com, a free, comprehensive savings site, now offers a special Holiday Deals section to its Cash Back Savings program, adding valuable savings opportunities when shopping online. Shoppers already can find more than 4,000 online coupon codes and, in addition, earn between 2% and 25% Cash Back when shopping at more than 1,200 online retail stores. The Holiday Deals area highlights the best deals available this shopping season.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/aol/47645/
Emmy® and Tony® award-winning actress Blythe Danner and Amgen (NASDAQ:AMGN) today launch Act 2 Reduce Fractures™, an educational campaign for women with postmenopausal osteoporosis at increased risk for fractures. Earlier this year, Danner was diagnosed with postmenopausal osteoporosis at increased risk for fractures and wants to encourage women like her to educate themselves, take action and speak to their doctors to learn all they can about helping to strengthen their bones. The campaign is being supported by American Bone Health, the Global Healthy Living Foundation and the Older Women’s League.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/amgen/48052/
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
Kumon, the world’s largest after-school math and reading enrichment company, seeks candidates to join its fast-growing franchise system. Candidates must qualify prior to the May 2 deadline to take advantage of the $27,500 in business incentives.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/kumon/43824/
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
